Search API | Precision Vaccinations

JFK Customs Screening Now Extended For Certain Passengers

Coronavirus 2019-nCoV diagnostic testing can be conducted at the CDC

January 18th, 2020

Fact checked by Robert Carlson, MD

Is It Time to Evaluate the FDA’s Expedited Approval Programs?

Legislative changes needed to ensure biologics, generics, and vaccines are worthwhile for patients

January 17th, 2020

Fact checked by Robert Carlson, MD

pregnant gal with cowboy boots on in Texas

Austin Confirms 1st Rubella Case in 20 Years

Pregnant women in Texas who are under immunized should avoid people infected with rubella

January 16th, 2020

Fact checked by Robert Carlson, MD

NantKwest ‘Triangle-Offense’ Induces Immunogenic Cell Death

NantKwest Inc. believes a common treatment protocol that harnesses both the natural-killer cell and the T cells could be effective in treating cancer across multiple tumor types

January 16th, 2020

Fact checked by Robert Carlson, MD

little rock arkansas capital of the state

Over 190 University Staff Out-of-Compliance With Vaccination Directive

University of Arkansas supervisors should tell staff to go home if not in compliance with the state mumps vaccination directive

January 16th, 2020

Fact checked by Danielle Reiter, RN

two young children walking down the road together

Asthma Reported Not a Risk Factor for Serious Illness Among Children With Influenza

Asthmatic children are encouraged to get annual flu vaccination by the CDC

January 16th, 2020

Fact checked by Robert Carlson, MD

Potential Glioblastoma Treatment Identified

Yale researchers introduced VEGF-C in conjunction with cancer immunotherapy drugs to target brain tumors

January 15th, 2020

Fact checked by Danielle Reiter, RN

NanoFlu is on the FDA’s Vaccine Fast-Track

Novavax NanoFlu is a recombinant quadrivalent seasonal influenza vaccine

January 15th, 2020

Fact checked by Danielle Reiter, RN

Parkinson’s Disease Treatment Launching Phase 2 Study in 2020

AFFiRiS announced it achieved proof of concept of its AFFITOME technology in humans for Parkinsons disease

January 15th, 2020

Fact checked by Robert Carlson, MD

Chikungunya Vaccine Candidate To Begin Testing in Europe

Emergent BioSolutions’ CHIKV-VLP vaccine is being developed for the prevention of disease caused by a chikungunya virus infection

January 14th, 2020

Fact checked by Robert Carlson, MD

Sponsored Links:

Discounts Appointments Clinical Trials Lab Tests